Alert share

ADVENTA (7191) : ADVENTA BERHAD

wow123
Today another company for sales is 7064 (latexx) because they knew that this for long run is not good , this case like adventa not small and not big in between. However rising production cost like labour and rubber also forex exchange for dollar down trend this key factor.
08 Oct 2012, 10:03 AM
juwelung
is the company going to bankrupt?
26 Dec 2012, 09:18 PM
Jusoh

Fair Value : RM2.00 | Recom : Market Perform (Cease Coverage)

Above expectations. Adventa’s 4QFY10/12 net profit of RM11.5m (+>100% yoy; +>100% qoq), was above our and consensus expectations with full-year FY12 net profit of RM25.5m (+93.8% yoy) accounting for 133% and 129% of our and consensus full-year net profit estimates respectively. Key variance was higher-than-expected EBIT margin of 7.4% vs. our full-year EBIT margin forecast of 6.8% as we had underestimated Adventa’s ability to retain savings arising from the lower latex prices. As expected, no dividend was declared during the quarter.

4Q earnings doubled qoq. Qoq, revenue was 10.2% higher thanks to a rapid ramp-up in nitrile glove production from seven new lines at the Johor plant. We believe this was partly offset by weaker US$ rate of RM3.08/US$ (3Q: RM3.15/US) and marginally lower ASPs to pass on the lower latex cost (-12.5% qoq). 4Q EBIT margin, however, saw a significant expansion of 4%-pts qoq thanks to the timelag in passing on the lower average latex price of RM5.94/kg (vs. RM6.79/kg in 3Q). Coupled with a tax writeback of RM0.8m for the quarter (vs. tax charge of RM0.2m in 3Q), 4Q net profit came in significantly higher at RM11.5m (vs. RM5.2m in 3Q).

Risks. The risks include: 1) sharp decline in latex price, which may result in margin expansion; and 2) a weaker RM against the US$.

Forecasts. We have increased our FY13-14 earnings forecasts by 18.6- 21.2%, after raising our FY13-14 nitrile glove ASP by 3% p.a.. Our numbers currently do not reflect the disposal of Adventa’s glove business as pending the completion of Adventa’s acquisition of Electron Beam for RM9m and the distribution of the amount equivalent to RM260m, Adventa remains largely a cash company.

Investment case. No change to our fair value of RM2.00, which is based on a 5% discount to Aspion’s takeover offer. Following the completion of Aspion’s purchase of Adventa on 30 Nov, Adventa had announced that the share will go ex- for the distribution of an amount equivalent to RM1.70/share on 4 Jan (payment on 21 Jan). We note that post-disposal, Adventa intends to maintain its listing status and would thus utilise the remaining RM61.1m to reinvent itself as an intergrated healthcare player with a focus on distribution of medical products, sterilisation services and peretonial dialysis home-treatment services. While Adventa’s peretonial dialysis business appears promising over the longer term, we note that the project is currently at a greenfield stage and thus bears a high execution risk. With the completion of the disposal of its glove business, we are ceasing coverage on the stock.

Source: RHB Research - 03 Jan 2013
From www.i3investor.com
04 Jan 2013, 06:57 PM
wow123
ahya this can go like today after ex. very good perform right because their business as long in healthcare is good.
04 Jan 2013, 10:10 PM
wow123
Yeh the horse still running all theway yes yes thumbupdroolyeahlol
07 Jan 2013, 10:05 AM
wow123

Nah bankrupt , now running like horse yes yes thumbupyeahdrool
07 Jan 2013, 10:59 AM
juwelung

Nah running like horse, now PN17 alreadyrolleyes
09 Jan 2013, 11:48 AM
wow123

please lah they have 12 month to submit their regulation plan.
10 Jan 2013, 11:31 AM
weathhunter
itz this share is still good for hold at long run questionquestion
05 Apr 2013, 11:39 AM
wow123


According medical device business are very high profit due many have common cancer like NPC 1 ratio 4 man 1 NPC among chinese , kidney etc. In penang private hospital , GMC , Aventist , Loh guan lye , Island & pantai , tanjong , Mount miriam cancer many visitor from around the world every years. For long run is good. In penang is best cancer treatment in malaysia because they tomohd latest generation gadget.
07 Aug 2013, 08:55 AM
wow123
adventa is back yes yes up up
24 Sep 2013, 03:30 PM
wow123
this having great day , moving forward
25 Sep 2013, 11:31 AM
ILoveDividend


Any good news?
25 Sep 2013, 11:38 AM
wow123
still a head and great day moving forward.
26 Sep 2013, 10:38 AM
jeloft
Still a PN17 company!?
28 Sep 2013, 05:04 PM
wow123
still a head today , as long they turn around good business that is good.
07 Oct 2013, 01:07 PM
wow123
According this counter still a head RM1 mark in 3 month after paying RM1,700.00 / share. That mean after ex. is around RM0,290 sen but today RM1,150. Horse still running.
17 Dec 2013, 05:32 PM
wow123
On tuesday 31.12.2013 they already submitted lifted PN17 , if sucessful will be not that prices for this share. For now at least RM2.00, The company get green light from bursa. Let see in one month !
02 Jan 2014, 07:10 PM
wow123
Kindly be advised that ADVENTA will be uplifted from being classified as a PN17 company effective 9.00 a.m. on 21 February 2014. For further details, kindly refer to the Company's announcement dated 20 February 2014.
20 Feb 2014, 07:31 PM
whytwocare

Best dividend stock analysis for 2020:

https://malaysiainvestment88.blogspot.com/2020/02/klse-best-dividend-stock-for-2020.html

02 Feb 2020, 12:43 AM

Overview Market Search portfolio More
Overview Market Search Portfolio More
Recently Viewed